Research reveals Sp100-HMG governs PML nuclear body formation via liquid-liquid phase separation, suggesting new roles in transcription and cell cycle regulation.
Promyelocytic leukemia nuclear bodies (PML NBs) are membraneless organelles (0.1-1 μm) integral to numerous fundamental cellular processes. Recent advances in cryo-EM and liquid-liquid phase separation (LLPS) research substantially advanced our understanding of PML NBs biophysical features and structural organization. Here, we identify Sp100-HMG, an Sp100 isoform, as a driver of PML NBs formation via LLPS, recruiting PML and accessory proteins (DAXX, ATRX). Dissection of this assembly process uncovered a hierarchical mechanism orchestrated by three distinct yet cooperative processes: I. Multimerization domain- and intrinsically disordered region (IDR)-mediated LLPS of Sp100-HMG, nucleating the initial core; II. C-terminal-dependent protein-protein interactions that enrich client components; and III. SUMOylation-directed PML recruitment, facilitating the formation of a stabilizing peripheral shell. Notably, this assembly paradigm extends beyond Sp100-HMG, as evidenced by ZBTB16, a PML NB-associated oncoprotein implicated in acute promyelocytic leukemia adopting an analogous mechanism to organize PML-positive condensates. Functional validation further revealed that Sp100-HMG positive PML NBs exert dual regulatory control over transcriptional programs and cell cycle progression, highlighting their pleiotropic roles. Critically, this work redefines the canonical PML NB assembly model by demonstrating that Sp100-HMG, rather than PML, acts as a primary scaffold, with PML polymerization relegated to a secondary, shell-forming stabilizer. By correlating the unique spatial architecture of Sp100-HMG positive PML NBs with their functional outputs, our findings establish a mechanistic framework for understanding how PML condensate biogenesis dictates transcriptional and cell cycle regulation, offering new avenues for exploring PML NB function in physical and disease contexts.
No takes yet. Share an insight, caveat, or question.
Dong et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: